Dr. Ashish B. Agrawal is an experienced Medical Oncologist, Haematologist and BMT specialist with more than 18 years of experience in the field of cancer care and blood disorders. He currently serves as Associate Director & Head (Unit II) – Medical Oncology, Haematology & BMT, where he is involved in the comprehensive evaluation and management of patients with a wide range of cancers and haematological conditions.
With a strong academic background and extensive clinical experience across leading hospitals, Dr. Agrawal focuses on providing evidence-based, personalised and multidisciplinary cancer care. His areas of expertise include breast cancer, head and neck cancers, gastrointestinal malignancies, lung cancer, lymphoma, immunotherapy and precision medicine.
His approach combines advanced medical oncology with careful patient assessment, appropriate treatment planning and compassionate communication, helping patients and their families understand their diagnosis and available treatment options.
Dr. Ashish B. Agrawal has undertaken extensive postgraduate training in General Medicine and Medical Oncology, building a strong foundation in the diagnosis and treatment of complex medical and oncological conditions.
His specialised training in Medical Oncology has helped him develop expertise in modern cancer treatment approaches, including systemic therapies, immunotherapy and precision-based treatment strategies.
With 18+ years of professional experience, Dr. Agrawal has worked with several reputed healthcare institutions across India. His diverse clinical experience has contributed to his expertise in managing both common and complex oncology and haematology cases.
This experience across different institutions has provided him with broad exposure to cancer diagnosis, systemic cancer therapies, haematological disorders and multidisciplinary patient management.
Dr. Agrawal is associated with several recognised national and international oncology organisations, reflecting his continued engagement with developments in cancer medicine. His memberships include:
These professional associations provide opportunities for ongoing academic engagement, knowledge exchange and awareness of evolving developments in oncology.
Dr. Ashish B. Agrawal's professional philosophy is centred on providing ethical, evidence-based and personalised cancer care. He strives to combine clinical experience with advances in modern oncology to offer patients appropriate treatment options while maintaining compassion and respect throughout their healthcare journey.
For Dr. Agrawal, effective cancer care extends beyond treating the disease—it involves understanding the patient, communicating clearly, supporting families and continuously working towards better treatment outcomes.

Dr. Ashish B. Agrawal is a Medical Oncologist, Haematologist and BMT specialist with expertise in managing various cancers and blood disorders, including breast cancer, lung cancer, lymphoma, gastrointestinal cancers, and head and neck cancers.
He provides medical oncology care for several cancers, including breast cancer, lung cancer, gastrointestinal malignancies, head and neck cancers, lymphoma, and other complex malignancies, depending on the patient's condition.
Yes, immunotherapy is one of Dr. Ashish's areas of expertise. It may be recommended for suitable patients based on their cancer type, stage, biomarkers, overall health, and treatment requirements.
Precision medicine involves using relevant tumour and patient-specific information to help select the most appropriate treatment. It can help doctors develop a more personalised approach to cancer management.
Yes. Dr. Ashish has expertise in Haematology and blood cancer management, including conditions such as lymphoma and other haematological malignancies. Treatment is planned according to the specific diagnosis and individual patient requirements.
With 18+ years of clinical experience in Medical Oncology and Haematology, Dr. Ashish offers comprehensive and personalised cancer care. His approach combines specialised expertise, evidence-based treatment, advanced oncology therapies, and compassionate patient care.